Ganirelix (sold as Ganirelix Acetate Injection 0.25 mg / 0.5 mL, among other brand names like Antagon and Orgalutran) is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist). According to the Ganirelix - Wikipedia entry and clinical guidelines, it is primarily used in assisted reproductive technology (ART) to control ovulation.
- Mechanism of Action: It works by competitively blocking GnRH receptors in the pituitary gland. This induces a rapid and reversible suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
- Primary Indication: It is prescribed to women undergoing controlled ovarian hyperstimulation (such as in IVF protocols) to prevent premature LH surges. Preventing this premature surge stops the ovaries from releasing eggs too early, ensuring the eggs can grow to full maturity before retrieval.